scholarly article | Q13442814 |
P356 | DOI | 10.1016/J.AJHG.2011.04.001 |
P8608 | Fatcat ID | release_idax4okiczaotecxcpv2xdjr5q |
P932 | PMC publication ID | 3146722 |
P698 | PubMed publication ID | 21529750 |
P5875 | ResearchGate publication ID | 51086075 |
P50 | author | Stacey S. Cherny | Q30505187 |
Hon-Cheong So | Q56884917 | ||
P2093 | author name string | Pak C Sham | |
Johnny S H Kwan | |||
P2860 | cites work | Potential etiologic and functional implications of genome-wide association loci for human diseases and traits | Q22066284 |
Estimation of significance thresholds for genomewide association scans | Q24289532 | ||
Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies | Q24531993 | ||
Screening for breast cancer: an update for the U.S. Preventive Services Task Force | Q24615837 | ||
Screening for breast cancer: U.S. Preventive Services Task Force recommendation statement | Q28265041 | ||
American Cancer Society guideline for the early detection of prostate cancer: update 2010 | Q28274848 | ||
Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study | Q28283241 | ||
A HapMap harvest of insights into the genetics of common disease | Q29614875 | ||
Screening and prostate-cancer mortality in a randomized European study | Q29617485 | ||
Number needed to screen: development of a statistic for disease screening. | Q30454244 | ||
Familial breast cancer: collaborative reanalysis of individual data from 52 epidemiological studies including 58,209 women with breast cancer and 101,986 women without the disease | Q30665466 | ||
??? | Q26995732 | ||
Overcoming the winner's curse: estimating penetrance parameters from case-control data | Q31105516 | ||
Benefits and harms of prostate-specific antigen screening for prostate cancer: an evidence update for the U.S. Preventive Services Task Force | Q33357480 | ||
Weighing the risks and benefits of tamoxifen treatment for preventing breast cancer | Q33765709 | ||
A unifying framework for evaluating the predictive power of genetic variants based on the level of heritability explained | Q33769562 | ||
Breast cancer susceptibility: current knowledge and implications for genetic counselling | Q34161642 | ||
Determining carrier probabilities for breast cancer-susceptibility genes BRCA1 and BRCA2 | Q34384153 | ||
On criteria for evaluating models of absolute risk | Q36072628 | ||
The BOADICEA model of genetic susceptibility to breast and ovarian cancer | Q36695832 | ||
Hereditary breast cancer: from bench to bedside. | Q37289132 | ||
Estimating risks of common complex diseases across genetic and environmental factors: the example of Crohn disease. | Q37363244 | ||
Systematic review: comparative effectiveness of medications to reduce risk for primary breast cancer | Q37634207 | ||
NCCN clinical practice guidelines in oncology: breast cancer screening and diagnosis | Q37636597 | ||
Assessing women at high risk of breast cancer: a review of risk assessment models | Q37739036 | ||
Family-based genetic risk prediction of multifactorial disease | Q39325731 | ||
Use and misuse of the receiver operating characteristic curve in risk prediction | Q40241086 | ||
Genetic susceptibility to breast cancer | Q41130542 | ||
Recurrence risks for multifactorial inheritance | Q41551199 | ||
Gauging the performance of SNPs, biomarkers, and clinical factors for predicting risk of breast cancer | Q42791172 | ||
Effect of age, breast density, and family history on the sensitivity of first screening mammography | Q45149178 | ||
Upward bias in odds ratio estimates from genome-wide association studies | Q46129490 | ||
Effect size measures in genetic association studies and age-conditional risk prediction | Q47414840 | ||
Genetic analysis of durations: correlated frailty model applied to survival of Danish twins. | Q50559114 | ||
A breast cancer prediction model incorporating familial and personal risk factors. | Q52000310 | ||
Evaluating the heritability explained by known susceptibility variants: a survey of ten complex diseases | Q57233959 | ||
The emerging landscape of breast cancer susceptibility | Q57272203 | ||
Projecting individualized probabilities of developing breast cancer for white females who are being examined annually | Q69396132 | ||
The multifactorial model for the inheritance of liability to disease and its implications for relatives at risk | Q69407093 | ||
Multifactorial qualitative traits: genetic analysis and prediction of recurrence risks | Q69737347 | ||
The inheritance of liability to diseases with variable age of onset, with particular reference to diabetes mellitus | Q72304054 | ||
Autosomal dominant inheritance of early-onset breast cancer. Implications for risk prediction | Q72752023 | ||
Risk estimation for healthy women from breast cancer families: new insights and new strategies | Q75337203 | ||
Polygenes, risk prediction, and targeted prevention of breast cancer | Q81523323 | ||
Screening for prostate cancer: U.S. Preventive Services Task Force recommendation statement | Q81740105 | ||
P433 | issue | 5 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | susceptibility locus | Q62091149 |
P304 | page(s) | 548-565 | |
P577 | publication date | 2011-04-28 | |
P1433 | published in | American Journal of Human Genetics | Q4744249 |
P1476 | title | Risk prediction of complex diseases from family history and known susceptibility loci, with applications for cancer screening | |
P478 | volume | 88 |
Q37589578 | A scoring strategy combining statistics and functional genomics supports a possible role for common polygenic variation in autism |
Q36055011 | Analysis of case-control association studies with known risk variants |
Q21144905 | Comparison of family history and SNPs for predicting risk of complex disease |
Q31064480 | Constructing Hypothetical Risk Data from the Area under the ROC Curve: Modelling Distributions of Polygenic Risk |
Q90575699 | Cumulative evidence for relationships between multiple variants of HNF1B and the risk of prostate and endometrial cancers |
Q37409157 | Cumulative impact of common genetic variants and other risk factors on colorectal cancer risk in 42,103 individuals |
Q30251440 | Developing and evaluating polygenic risk prediction models for stratified disease prevention |
Q28084601 | Do Health Professionals Need Additional Competencies for Stratified Cancer Prevention Based on Genetic Risk Profiling? |
Q96576411 | Efficient polygenic risk scores for biobank scale data by exploiting phenotypes from inferred relatives |
Q90929499 | Estimation of complex effect-size distributions using summary-level statistics from genome-wide association studies across 32 complex traits |
Q36524374 | Explicit Modeling of Ancestry Improves Polygenic Risk Scores and BLUP Prediction |
Q39033094 | Exploring the predictive power of polygenic scores derived from genome-wide association studies: a study of 10 complex traits |
Q34943534 | Genetic and environmental components of family history in type 2 diabetes |
Q27027720 | Genetic risk prediction in complex disease |
Q47994728 | Improving Disease Prediction by Incorporating Family Disease History in Risk Prediction Models with Large-Scale Genetic Data |
Q42145797 | Improving polygenic risk prediction from summary statistics by an empirical Bayes approach |
Q37614763 | Incorporating genomics into breast and prostate cancer screening: assessing the implications |
Q92095785 | Liability threshold modeling of case-control status and family history of disease increases association power |
Q35899657 | Machine learning derived risk prediction of anorexia nervosa |
Q48232613 | Multifactorial disease risk calculator: Risk prediction for multifactorial disease pedigrees |
Q33896815 | Pitfalls of predicting complex traits from SNPs |
Q30734382 | Polygenic risk and the development and course of asthma: an analysis of data from a four-decade longitudinal study |
Q38798713 | Polygenic scores via penalized regression on summary statistics |
Q39782065 | Predicting quantitative traits from genome and phenome with near perfect accuracy |
Q36583004 | Prediction of breast cancer risk based on profiling with common genetic variants |
Q41584352 | Prediction of individual genetic risk to prostate cancer using a polygenic score |
Q37059182 | Projecting the performance of risk prediction based on polygenic analyses of genome-wide association studies |
Q34434004 | Research review: Polygenic methods and their application to psychiatric traits |
Q90175282 | The Maudsley environmental risk score for psychosis |
Q37578078 | The OncoArray Consortium: A Network for Understanding the Genetic Architecture of Common Cancers |
Q35547325 | The contribution of genetic variants to disease depends on the ruler |
Q36339854 | Two-Variance-Component Model Improves Genetic Prediction in Family Datasets. |
Q36255311 | Using Breast Cancer Risk Associated Polymorphisms to Identify Women for Breast Cancer Chemoprevention |
Search more.